| Identification | Back Directory | [Name]
D-HOMOCYSTINE | [CAS]
6027-15-2 | [Synonyms]
D-HOMOCYSTINE
(H-D-HOCYS-OH)2
(H-D-Hcys-OH) 2
D-4,4'-DITHIOBIS[2-AMINOBUTANOIC ACID]
(R,R)-4,4-DITHIOBIS(2-AMINOBUTANOIC ACID)
Butanoic acid, 4,4'-dithiobis[2-aMino-, (2R,2'R)-
(2R,2'R)-4,4'-Disulfanediylbis(2-aminobutanoic acid)
(2R)-2-amino-4-[[(3R)-3-amino-3-carboxypropyl]disulfanyl]butanoic acid | [Molecular Formula]
C8H16N2O4S2 | [MDL Number]
MFCD00068281 | [MOL File]
6027-15-2.mol | [Molecular Weight]
268.35 |
| Chemical Properties | Back Directory | [Melting point ]
>229°C (dec.) | [Boiling point ]
507.6±50.0 °C(Predicted) | [density ]
1.443±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Inert atmosphere,2-8°C | [solubility ]
Aqueous Acid (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
1.90±0.10(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
D-Homocysteine is the stereoisomer of L-Homocystine, increased levels lead to hyperhomocysteinemia; a cardiovascular risk factor in prediction of coronary heart disease as well as being associated wit
h congenital birth defects, pregnancy complications and cancer. | [Uses]
D-Homocysteine is the stereoisomer of L-Homocystine, increased levels lead to hyperhomocysteinemia; a cardiovascular risk factor in prediction of coronary heart disease as well as being associated with congenital birth defects, pregnancy complications and cancer. | [Biological Activity]
D-Homocystine may be used in the preparation of carbocyclic nucleoside such as S-aristeromycinyl-L-homocysteine for use in studied on S-adenosylmethionine-dependent methyltransferase inhibitors. |
|
|